Elon Musk and Sam Altman arrive in court for trial that could reshape AI’s future
Elon Musk and Sam Altman are embroiled in a high-stakes trial that could significantly impact the future of artificial intelligence. Musk has accused Altman and his team of straying from OpenAI's original mission and seeks damages as well as Altman's removal from the board. The trial, which began with jury selection, is expected to reveal intricate details about their contentious relationship and the evolution of OpenAI.
- ▪Elon Musk is suing Sam Altman and Greg Brockman over allegations of straying from OpenAI's founding mission.
- ▪Musk claims that OpenAI has shifted from a non-profit to a for-profit entity, violating its original commitments.
- ▪The trial is expected to last three weeks and will delve into the complex relationship between Musk and Altman.
3 outlets in our directory ran this story, first to last over 4 hours. All of the coverage we found sits in one bucket: centre. That one-sidedness is itself worth noticing.
The Globe and Mail publishes from Canada and files mainly under world. We currently carry 1,816 of its stories.
Opening excerpt (first ~120 words) tap to expand
Open this photo in gallery:Elon Musk arrives at the U.S. District Court in Oakland on Tuesday. The high-stakes trial revolves around a bitter feud between the former friends.Godofredo A. Vásquez/The Associated PressShareSave for laterPlease log in to bookmark this story.Log InCreate Free AccountElon Musk, the Tesla CEO, world’s richest man and OpenAI cofounder, took the stand Tuesday in a high-stakes trial revolving around a bitter feud with his former friend Sam Altman that could reshape the future development of artificial intelligence.His testimony at the Oakland, California, federal courthouse kicked off a legal drama that is expected to brim with intrigue and potentially embarrassing details about the two tech moguls.
…
Excerpt limited to ~120 words for fair-use compliance. The full article is at The Globe and Mail.
Discussion
0 commentsMore from The Globe and Mail
